Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current HIV Research|March 27, 2004
Sugar and spice: viral envelope-DC-SIGN interactions in HIV pathogenesisStephen V Su, Kevin B Gurney, Benhur LeeJournal of Virology|February 14, 2004
Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGNAymeric de Parseval, Stephen V Su, John H Elder, et al.Journal of Virology|May 25, 2007
Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120Patrick W-P Hong, Sandra Nguyen, Sophia Young, et al.The Journal of Biological Chemistry|February 19, 2004
DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3Stephen V Su, Patrick Hong, Sarah Baik, et al.Methods in Enzymology|January 3, 2012
Optimizing properties of antireceptor antibodies using kinetic computational models and experimentsBrian D Harms, Jeffrey D Kearns, Stephen V Su, et al.Plos Pathogens|February 16, 2006
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virusOscar A Negrete, Mike C Wolf, Hector C Aguilar, et al.Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
mRNA structure regulates protein expression through changes in functional half-lifeDavid M Mauger, B Joseph Cabral, Vladimir Presnyak, et al.Science Advances|July 9, 2020
Impact of mRNA chemistry and manufacturing process on innate immune activationJennifer Nelson, Elizabeth W Sorensen, Shrutika Mintri, et al.Journal of Virology|April 28, 2006
N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entryHector C Aguilar, Kenneth A Matreyek, Claire Marie Filone, et al.Science Translational Medicine|February 1, 2019
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAsSusannah L Hewitt, Ailin Bai, Dyane Bailey, et al.Pageof 2